Interpace Biosciences logo
Interpace Biosciences IDXG
$ 2.68 0.0%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Interpace Biosciences Financial Statements 2011-2024 | IDXG

Annual Financial Statements Interpace Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

5.96 M 4.66 M 22.3 M 16.2 M 28.6 M 25.3 M 17.3 M 7.55 M 4.18 M 23.2 M 86.5 M 112 M 95.7 M

Shares

4.32 M 4.24 M 4.14 M 4.03 M 3.75 M 2.82 M 1.58 M 182 K 155 K 149 K 147 K 146 K 144 K

Historical Prices

1.38 1.1 5.39 4.02 7.91 9.2 10.8 41.7 27 156 579 775 641

Net Income

802 K -22 M -14.9 M -26.5 M -26.7 M -12.2 M -12.2 M -8.33 M -11.4 M -16.1 M -4.56 M -25.5 M -11.9 M

Revenue

40.2 M 31.8 M 8.2 M 32.4 M 24.1 M 21.9 M 15.9 M 13.1 M 9.43 M 120 M 151 M 127 M 157 M

Cost of Revenue

16.3 M 13.6 M 14.3 M 21.7 M 15.9 M 10.2 M 7.36 M 6.64 M 6.91 M 1.27 M 17.4 M 16.4 M 19.7 M

Gross Profit

23.9 M 18.2 M 18.8 M 10.7 M 8.19 M 11.7 M 8.54 M 6.44 M 2.52 M 18.5 M 24.4 M 26.9 M 32.5 M

Operating Income

2.8 M -3.62 M -6.34 M -26.1 M -26.4 M -12.6 M -6.29 M -6.44 M -40.4 M -17.8 M -1.44 M -25.2 M -4.7 M

Interest Expense

-667 K -1.21 M -366 K 549 K 440 K 331 K 433 K 14 K -93 K 602 K - -28 K -14 K

EBITDA

3.83 M -1.06 M -962 K -22.1 M -16 M -4.09 M -5.39 M -7.4 M -23.2 M -9.84 M -2.85 M 1.02 M -1.66 M

Operating Expenses

21.1 M 21.8 M 25.1 M 37.3 M 28.4 M 19 M 17.2 M 17.6 M 29.6 M 29.2 M 28.7 M 27.9 M 37.2 M

General and Administrative Expenses

9.36 M 11 M 10.7 M 20.8 M 14.5 M 8.5 M 9.15 M 10.5 M 16.9 M 29.2 M 28.7 M 27.9 M 34.3 M

All numbers in USD currency

Quarterly Income Statement Interpace Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

4.39 M 4.38 M 4.37 M 4.35 M 4.32 M 4.31 M 4.31 M 4.3 M 4.24 M 4.23 M 4.21 M 4.2 M 4.16 M 4.1 M 4.09 M 4.06 M 4.04 M 4.03 M 4 M 3.92 M 3.82 K 3.81 M 3.52 M 2.87 M 28.2 K 27.9 M 27.9 M 27.8 M 22 M 9.66 M 4.29 M 2.18 M 1.82 M 1.82 M 1.78 M 1.77 M 15.7 M 15.2 M 15 M 15.4 M 14.9 M 14.9 M 14.8 M 15.2 M 14.7 M 14.7 M 15 M 15 M 14.6 M 14.6 M 14.5 M 14.7 M 14.5 M 14.4 M 14.5 M

Net Income

1.28 M 2.06 M 468 K - -614 K 175 K 351 K - -14.2 M -3.94 M -2.25 M - -3.56 M -3.45 M -4.21 M -8.14 M -6.23 M -5.58 M -6.49 M -10.7 M -7.45 M -5.3 M -3.33 M -4.3 M -3.13 M -2 M -3.28 M - -3.4 M -6.39 M 2.33 M - -8 M -2.84 M -5.3 M - -5.4 M -7.49 M -4.61 M - -4.45 M -2.66 M -1.61 M - -2.14 M -883 K 2.13 M - -1.02 M -439 K -272 K - -202 K -895 K -550 K

Revenue

12.3 M 12 M 10.3 M - 9.08 M 11 M 9.83 M - 1.27 M 1.96 M 2.45 M - 8.06 M 11.2 M 9.83 M - 8.25 M 5.45 M 9.06 M - 7.72 M 6.27 M 6.01 M - 5.75 M 5.5 M 4.81 M - 4.2 M 3.86 M 3.47 M - 3.32 M 3.61 M 3.04 M - 2.51 M 2.25 M 2.12 M - 29.2 M 31.6 M 32.8 M - 34.3 M 37.2 M 42.9 M - 31.8 M 27.8 M 31.7 M - 36.1 M 38.6 M 44.3 M

Cost of Revenue

4.79 M 4.61 M 4.2 M - 4.12 M 4.19 M 3.85 M - 3.46 M 3.56 M 3.26 M - 3.62 M 5.8 M 5.32 M - 5.19 M 3.85 M 6.11 M - 4.84 M 3.03 M 2.62 M - 2.76 M 2.25 M 2.58 M - 2.07 M 1.88 M 1.77 M - 1.85 M 1.84 M 1.18 M - 1.8 M 1.85 M 1.57 M - 24.4 M 25.8 M 26.7 M - 4.23 M 4.91 M 4.16 M - 4.08 M 4.07 M 4.58 M - 4.17 M 5.7 M 5.28 M

Gross Profit

7.51 M 7.43 M 6.07 M - 4.95 M 6.84 M 5.98 M - 4.73 M 3.83 M 4.66 M - 4.44 M 5.36 M 4.52 M - 3.05 M 1.6 M 2.95 M - 2.89 M 3.24 M 3.39 M - 2.99 M 3.25 M 2.23 M - 2.13 M 1.98 M 1.7 M - 1.47 M 1.77 M 1.86 M - 707 K 402 K 543 K - 3.85 M 5.19 M 5.12 M - 4.7 M 6.85 M 8.47 M - 5.94 M 6.57 M 7.37 M - 7.68 M 7.93 M 8.16 M

Operating Income

1.9 M 2.26 M 874 K - -16 K 832 K 675 K - -780 K -1.91 M -977 K - -1.82 M -2.91 M -3.82 M - -6 M -5.77 M -6.35 M - -7.13 M -5.35 M -3.18 M - -2.46 M -1.9 M -3.25 M - -3.1 M -3.6 M 3.7 M - -6.49 M -2.89 M -3.8 M - -6.65 M -7.71 M -6.12 M - -3.2 M -1.06 M -414 K - -2.05 M -847 K 2.25 M - -756 K -316 K -221 K - 195 K -1.07 M -1.39 M

Interest Expense

- 71 K -82 K - -252 K -174 K 19 K - -217 K 37 K 161 K - 49 K -168 K 135 K - 138 K 167 K 109 K - 111 K 91 K 129 K - 248 K 33 K 111 K - 40 K -8 K -36 K - 4 K 3 K 6 K - 969 K 884 K 848 K - - - - - 3 K -24 K -9 K - - -15 K -1 K - -48 K -26 K -65 K

EBITDA

- - 926 K - 184 K 1.13 M 1.03 M - -480 K -1.61 M -196 K - 2.52 M 37 K -2.28 M - -1.9 M -3.06 M -5.03 M - -3.97 M -3.43 M -2.23 M - 115 K -188 K -2.39 M - -282 K -1.66 M 4.67 M - -3 M -504 K -2.54 M - -2.88 M -5.21 M -4.93 M - -1.87 M -225 K 43 K - -1.13 M -270 K 2.54 M - 734 K 680 K 280 K - 2.55 M 493 K -604 K

Operating Expenses

5.6 M 5.17 M 5.2 M - 4.97 M 6 M 5.3 M - 5.51 M 5.74 M 5.64 M - 6.26 M 8.26 M 8.33 M - 9.06 M 7.37 M 9.3 M - 10 M 8.59 M 6.57 M - 5.46 M 5.15 M 5.48 M - 5.23 M 5.57 M -2 M - 7.96 M 4.66 M 5.66 M - 7.36 M 8.12 M 6.67 M - 7.06 M 6.26 M 5.53 M - 6.75 M 7.7 M 6.22 M - 6.7 M 6.89 M 7.59 M - 7.48 M 9 M 9.55 M

General and Administrative Expenses

2.54 M 2.14 M 2.24 M - 2.12 M 2.89 M 2.49 M - 2.77 M 2.98 M 2.89 M - 2.57 M 3.33 M 2.98 M - 3.8 M 3.98 M 4.84 M - 4.49 M 2.79 M 2.74 M - 2.08 M 1.73 M 2.17 M - 2.12 M 2.79 M 1.52 M - 2.86 M 2.02 M 2.82 M - 2.5 M 3.43 M 3.34 M - 6.93 M 6.26 M 5.53 M - - - - - - - - - - - -

All numbers in USD currency